Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China

Objectives: To access the cost of illness, quality of life and work limitation in active ankylosing spondylitis (AS) patients using adalimumab in China. Methods: A prospective study was performed in 91 patients with active AS in China. Adult patients (aged ≥ 18 years) fulfilled the 1984 New York mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Liudan, Xie, Ya, Liao, Zetao, Jiang, Yutong, Lv, Qing, Cao, Shuangyan, Wei, Qiujing, Gu, Jieruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732412/
https://www.ncbi.nlm.nih.gov/pubmed/33330342
http://dx.doi.org/10.3389/fpubh.2020.602334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732412/
https://www.ncbi.nlm.nih.gov/pubmed/33330342
http://dx.doi.org/10.3389/fpubh.2020.602334

Ejemplares similares